Literature DB >> 22016370

Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Christina C Kao1, Jean W-C Hsu, Venkata Bandi, Nicola A Hanania, Farrah Kheradmand, Farook Jahoor.   

Abstract

The mechanisms leading to weight loss in patients with chronic obstructive pulmonary disease (COPD) are poorly understood but may involve alterations in macronutrient metabolism. Changes in muscle oxidative capacity and lactate production during exercise suggest glucose metabolism may be altered in COPD subjects. The objective of this study was to determine differences in the rates of glucose production and clearance, the rate of glycolysis (pyruvate production), and oxidative and nonoxidative pyruvate disposal in subjects with severe COPD compared with healthy controls. The in vivo rates of glucose production and clearance were measured in 14 stable outpatients with severe COPD (seven with low and seven with preserved body mass indexes) and 7 healthy controls using an intravenous infusion of [(2)H(2)]glucose. Additionally, pyruvate production and oxidative and non-oxidative pyruvate disposal were measured using intravenous infusions of [(13)C]bicarbonate and [(13)C]pyruvate. Endogenous glucose flux and glucose clearance were significantly faster in the combined COPD subjects (P = 0.002 and P < 0.001, respectively). This difference remained significant when COPD subjects were separated by body mass index. Pyruvate flux and oxidation were significantly higher in the combined COPD subjects than controls (P = 0.02 for both), but there was no difference in nonoxidative pyruvate disposal or plasma lactate concentrations between the two groups. In subjects with severe COPD, there are alterations in glucose metabolism leading to increased glucose production and faster glucose metabolism by glycolysis and oxidation compared with controls. However, no difference in glucose conversion to lactate via pyruvate reduction is observed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016370      PMCID: PMC3290418          DOI: 10.1152/japplphysiol.00599.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  31 in total

Review 1.  Hydration of fat-free body mass: review and critique of a classic body-composition constant.

Authors:  Z Wang; P Deurenberg; W Wang; A Pietrobelli; R N Baumgartner; S B Heymsfield
Journal:  Am J Clin Nutr       Date:  1999-05       Impact factor: 7.045

2.  Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease.

Authors:  A Hjalmarsen; U Aasebø; K Birkeland; G Sager; R Jorde
Journal:  Diabetes Metab       Date:  1996-02       Impact factor: 6.041

3.  Revised equations for calculating CO2 production from doubly labeled water in humans.

Authors:  J R Speakman; K S Nair; M I Goran
Journal:  Am J Physiol       Date:  1993-06

4.  Evaluation of the isotopic equilibration between lactate and pyruvate.

Authors:  R R Wolfe; F Jahoor; H Miyoshi
Journal:  Am J Physiol       Date:  1988-04

5.  Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease.

Authors:  E M Pouw; A M Schols; G J van der Vusse; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

6.  Resting energy expenditure in patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; E W Fredrix; P B Soeters; K R Westerterp; E F Wouters
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

7.  Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function.

Authors:  E C Creutzberg; A M Schols; F C Bothmer-Quaedvlieg; E F Wouters
Journal:  Eur J Clin Nutr       Date:  1998-06       Impact factor: 4.016

8.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

Authors:  F Maltais; A A Simard; C Simard; J Jobin; P Desgagnés; P LeBlanc
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

9.  Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.

Authors:  P Jakobsson; L Jorfeldt; J Henriksson
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

10.  Insulin resistance is not exhibited by advanced chronic obstructive pulmonary disease patients.

Authors:  P Jakobsson; L Jorfeldt; H von Schenck
Journal:  Clin Physiol       Date:  1995-11
View more
  13 in total

1.  FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis?

Authors:  Gregory A Hawkins; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

2.  Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.

Authors:  Nilanjana Ghosh; Priyanka Choudhury; Elavarasan Subramani; Dipanjan Saha; Sayoni Sengupta; Mamata Joshi; Rintu Banerjee; Sushmita Roychowdhury; Parthasarathi Bhattacharyya; Koel Chaudhury
Journal:  Metabolomics       Date:  2019-06-04       Impact factor: 4.290

Review 3.  Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.

Authors:  Haifeng Zhao; Phyllis A Dennery; Hongwei Yao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-04       Impact factor: 5.464

4.  Acrolein inhalation acutely affects the regulation of mitochondrial metabolism in rat lung.

Authors:  C B M Tulen; S J Snow; P A Leermakers; U P Kodavanti; F J van Schooten; A Opperhuizen; A H V Remels
Journal:  Toxicology       Date:  2022-02-10       Impact factor: 4.571

5.  Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.

Authors:  Chengjian Tu; Manoj Jacob Mammen; Jun Li; Xiaomeng Shen; Xiaosheng Jiang; Qiang Hu; Jianmin Wang; Sanjay Sethi; Jun Qu
Journal:  J Proteome Res       Date:  2013-12-02       Impact factor: 4.466

6.  Respiratory metabolites in bronchoalveolar lavage fluid (BALF) and exhaled breath condensate (EBC) can differentiate horses affected by severe equine asthma from healthy horses.

Authors:  Marilena Bazzano; Luca Laghi; Chenglin Zhu; Gian Enrico Magi; Beniamino Tesei; Fulvio Laus
Journal:  BMC Vet Res       Date:  2020-07-08       Impact factor: 2.741

7.  1H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide.

Authors:  Li-Chuan Tan; Wen-Jie Yang; Wei-Ping Fu; Ping Su; Jing-Kui Shu; Lu-Ming Dai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-27

8.  Quadriceps strength in patients with chronic obstructive pulmonary disease.

Authors:  Swati Shah; Bhushan Darekar; Sundeep Salvi; Arun Kowale
Journal:  Lung India       Date:  2019 Sep-Oct

9.  Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).

Authors:  Nilanjana Ghosh; Priyanka Choudhury; Sandeep Rai Kaushik; Rakesh Arya; Ranjan Nanda; Parthasarathi Bhattacharyya; Sushmita Roychowdhury; Rintu Banerjee; Koel Chaudhury
Journal:  Respir Res       Date:  2020-05-24

10.  Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Authors:  Lingling Wang; Yufu Tang; Shuo Liu; Shitao Mao; Yuan Ling; Dan Liu; Xiaoyu He; Xiaoge Wang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.